Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suguru Shirotake

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
BJU International|June 26, 2013
Patient characteristics and outcomes in metastatic upper tract urothelial carcinoma after radical nephroureterectomy: the experience of Japanese multi-institutionsNobuyuki Tanaka, Eiji Kikuchi, Kent Kanao, et al.
European Urology|December 11, 2012
The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional studyNobuyuki Tanaka, Eiji Kikuchi, Suguru Shirotake, et al.
Urologic Oncology|September 24, 2013
The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional studyNobuyuki Tanaka, Eiji Kikuchi, Kent Kanao, et al.
Annals of Surgical Oncology|November 13, 2013
Metastatic behavior of upper tract urothelial carcinoma after radical nephroureterectomy: association with primary tumor locationNobuyuki Tanaka, Eiji Kikuchi, Kent Kanao, et al.
International Journal of Clinical Oncology|June 11, 2020
A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world dataNobuyuki Hinata, Junji Yonese, Satoru Masui, et al.
Annals of Surgical Oncology|April 1, 2014
Independent predictors for bladder outcomes after treatment of intravesical recurrence following radical nephroureterectomy in patients with primary upper tract urothelial carcinomaNobuyuki Tanaka, Eiji Kikuchi, Kent Kanao, et al.
Annals of Surgical Oncology|June 11, 2014
A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomyNobuyuki Tanaka, Eiji Kikuchi, Kent Kanao, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 30, 2023
Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart reviewJunji Yonese, Nobuyuki Hinata, Satoru Masui, et al.
The Journal of Urology|December 3, 2014
Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experienceSuguru Shirotake, Eiji Kikuchi, Nobuyuki Tanaka, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
BJU International|June 26, 2013
Patient characteristics and outcomes in metastatic upper tract urothelial carcinoma after radical nephroureterectomy: the experience of Japanese multi-institutionsNobuyuki Tanaka, Eiji Kikuchi, Kent Kanao, et al.
European Urology|December 11, 2012
The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional studyNobuyuki Tanaka, Eiji Kikuchi, Suguru Shirotake, et al.
Urologic Oncology|September 24, 2013
The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional studyNobuyuki Tanaka, Eiji Kikuchi, Kent Kanao, et al.
Annals of Surgical Oncology|November 13, 2013
Metastatic behavior of upper tract urothelial carcinoma after radical nephroureterectomy: association with primary tumor locationNobuyuki Tanaka, Eiji Kikuchi, Kent Kanao, et al.
International Journal of Clinical Oncology|June 11, 2020
A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world dataNobuyuki Hinata, Junji Yonese, Satoru Masui, et al.
Annals of Surgical Oncology|April 1, 2014
Independent predictors for bladder outcomes after treatment of intravesical recurrence following radical nephroureterectomy in patients with primary upper tract urothelial carcinomaNobuyuki Tanaka, Eiji Kikuchi, Kent Kanao, et al.
Annals of Surgical Oncology|June 11, 2014
A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomyNobuyuki Tanaka, Eiji Kikuchi, Kent Kanao, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 30, 2023
Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart reviewJunji Yonese, Nobuyuki Hinata, Satoru Masui, et al.
The Journal of Urology|December 3, 2014
Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experienceSuguru Shirotake, Eiji Kikuchi, Nobuyuki Tanaka, et al.
Pageof 9